INTERNATIONAL PATENT: FORTVITA BIOLOGICS INC. FILES APPLICATION FOR "ANTIBODY DRUG CONJUGATES TARGETING B7-H3 AND TROP2 AND THE USE THEREOF"

GENEVA, June 30 -- FORTVITA BIOLOGICS INC. (Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205) filed a patent application (PCT/CN2024/140994) for "ANTIBODY DRUG CONJUGATES TARGETING B7-H3 AND TROP2 AND THE USE THEREOF" on Dec 20, 2024. With publication no. WO/2025/131063, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Bo (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), LI, Bin (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu...